HK1121757A1 - Pyrroloazacyclic derivatives, preparing method and use thereof - Google Patents

Pyrroloazacyclic derivatives, preparing method and use thereof

Info

Publication number
HK1121757A1
HK1121757A1 HK09101628.9A HK09101628A HK1121757A1 HK 1121757 A1 HK1121757 A1 HK 1121757A1 HK 09101628 A HK09101628 A HK 09101628A HK 1121757 A1 HK1121757 A1 HK 1121757A1
Authority
HK
Hong Kong
Prior art keywords
pyrroloazacyclic
derivatives
preparing method
preparing
pyrroloazacyclic derivatives
Prior art date
Application number
HK09101628.9A
Other languages
English (en)
Inventor
Peng Cho Tang
Yidong Su
Yali Li
Lei Zhang
Fuqiang Zhao
Jialiang Yang
Ying Zhou
Pingyan Bie
Guangtao Qian
Minggang Ju
Original Assignee
Shanghai Hengrui Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Hengrui Pharm Co Ltd filed Critical Shanghai Hengrui Pharm Co Ltd
Publication of HK1121757A1 publication Critical patent/HK1121757A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
HK09101628.9A 2007-05-14 2009-02-20 Pyrroloazacyclic derivatives, preparing method and use thereof HK1121757A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200710107463 2007-05-14

Publications (1)

Publication Number Publication Date
HK1121757A1 true HK1121757A1 (en) 2009-04-30

Family

ID=40001668

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09101628.9A HK1121757A1 (en) 2007-05-14 2009-02-20 Pyrroloazacyclic derivatives, preparing method and use thereof
HK10104918.9A HK1137027A1 (en) 2007-05-14 2010-05-19 Pyrrolo-nitrogenous heterocyclic derivatives and the pharmaceutical use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10104918.9A HK1137027A1 (en) 2007-05-14 2010-05-19 Pyrrolo-nitrogenous heterocyclic derivatives and the pharmaceutical use thereof

Country Status (13)

Country Link
US (2) US8329682B2 (fr)
EP (1) EP2157093A4 (fr)
JP (1) JP5342547B2 (fr)
KR (1) KR20100022003A (fr)
CN (2) CN101307052B (fr)
AU (1) AU2008250895B2 (fr)
BR (1) BRPI0811865A2 (fr)
CA (1) CA2685757A1 (fr)
HK (2) HK1121757A1 (fr)
MX (1) MX2009011964A (fr)
TW (1) TWI409263B (fr)
UA (1) UA99617C2 (fr)
WO (1) WO2008138184A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008138184A1 (fr) * 2007-05-14 2008-11-20 Shanghai Hengrui Pharmaceutical Co.Ltd. Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
WO2011056985A2 (fr) * 2009-11-04 2011-05-12 Gilead Sciences, Inc. Composés hétérocycliques substitués
CN102146082A (zh) * 2010-02-04 2011-08-10 江苏恒瑞医药股份有限公司 吡咯并n杂环类衍生物的可药用的盐、其制备方法及其在医药上的应用
PL3205654T3 (pl) 2010-05-20 2019-08-30 Array Biopharma, Inc. Związki makrocykliczne jako inhibitory kinazy TRK
ES2748873T3 (es) 2012-01-26 2020-03-18 Angion Biomedica Corp Compuestos antifibróticos y usos de los mismos
AU2013299922B2 (en) * 2012-08-07 2018-06-21 Janssen Pharmaceutica Nv Process for the preparation of heterocyclic ester derivatives
CN104119321B (zh) * 2013-04-28 2017-09-08 齐鲁制药有限公司 二氢吲哚酮衍生物的二马来酸盐及其多晶型物
KR20180041135A (ko) 2015-07-16 2018-04-23 어레이 바이오파마 인크. Ret 키나아제 억제제로서 치환된 피라졸로[1,5-a]피리딘 화합물
CN108601778A (zh) * 2016-01-08 2018-09-28 正大天晴药业集团股份有限公司 喹啉衍生物用于治疗食管癌的用途及其治疗方法、药物组合物和试剂盒
JOP20190077A1 (ar) 2016-10-10 2019-04-09 Array Biopharma Inc مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
TWI704148B (zh) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
CN110267960B (zh) 2017-01-18 2022-04-26 阿雷生物药品公司 作为RET激酶抑制剂的取代的吡唑并[1,5-a]吡嗪化合物
WO2018136663A1 (fr) 2017-01-18 2018-07-26 Array Biopharma, Inc. Inhibiteurs de ret
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
EP3628044B1 (fr) * 2017-05-15 2023-11-22 The Regents of The University of Michigan Pyrrolo[2,3]pyridines et leurs analogues associés en tant qu' inhibiteurs de lsd-1
TWI791053B (zh) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
TWI812649B (zh) 2017-10-10 2023-08-21 美商絡速藥業公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
US11261158B2 (en) 2017-11-17 2022-03-01 Fermion Oy Synthesis of 2-indolinone derivatives
JP6997876B2 (ja) 2018-01-18 2022-02-04 アレイ バイオファーマ インコーポレイテッド Ｒｅｔキナーゼ阻害剤としての置換ピラゾリル［４，３－ｃ］ピリジン化合物
CA3087354C (fr) 2018-01-18 2023-01-03 Array Biopharma Inc. Composes de pyrrolo[2,3-d]pyrimidines substitues utilises en tant qu'inhibiteurs de la kinase ret
JP7061195B2 (ja) 2018-01-18 2022-04-27 アレイ バイオファーマ インコーポレイテッド ＲＥＴキナーゼ阻害剤としての置換ピラゾロ［３，４－ｄ］ピリミジン化合物
ES2922314T3 (es) 2018-09-10 2022-09-13 Array Biopharma Inc Compuestos heterocíclicos condensados como inhibidores de cinasa RET
CN112538086B (zh) * 2020-12-14 2021-11-12 承德医学院 杂卓并三唑环同吲哚羧酸拼合物及其盐、其制备方法及医药用途
CN113634240B (zh) * 2021-08-26 2023-10-27 宏葵生物（中国）股份有限公司 荧光磁性复合纳米纤维、其制备方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866702A (en) 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
EP1066257A2 (fr) * 1998-03-26 2001-01-10 Sugen, Inc. Familles heterocycliques de composes destinees a la modulation de la tyrosine-kinase
DE60029138T2 (de) * 1999-12-22 2007-06-06 Sugen, Inc., San Francisco Verwendung von Indolinonverbindungen zur Herstellung von Pharmazeutika für die Modulation der Funktion c-kit Proteintyrosinkinase
SI1255752T1 (sl) 2000-02-15 2007-12-31 Pharmacia & Upjohn Co Llc S pirolom substituirani zaviralci 2-indolinon protein kinaza
US6465507B2 (en) * 2000-02-28 2002-10-15 Sugen, Inc. 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
JP2003535847A (ja) 2000-06-02 2003-12-02 スージェン・インコーポレーテッド 蛋白質キナーゼ／ホスファターゼ阻害剤としてのインドリノン誘導体
US6635640B2 (en) * 2000-06-30 2003-10-21 Sugen, Inc. 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
PE20020776A1 (es) * 2000-12-20 2002-08-22 Sugen Inc Indolinonas 4-aril sustituidas
US6599902B2 (en) 2001-05-30 2003-07-29 Sugen, Inc. 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
US6777417B2 (en) * 2001-09-10 2004-08-17 Sugen, Inc. 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors
US20040186160A1 (en) * 2002-12-13 2004-09-23 Sugen, Inc. Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors
US8012966B2 (en) * 2006-01-27 2011-09-06 Shanghai Hengrui Pharmaceutical Co., Ltd. Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
CN101007814A (zh) * 2006-01-27 2007-08-01 上海恒瑞医药有限公司 吡咯并六元杂环化合物及其在医药上的用途
CN101007815B (zh) * 2006-01-27 2010-06-23 江苏恒瑞医药股份有限公司 吡咯并六元杂环化合物及其在医药上的用途
WO2008138184A1 (fr) * 2007-05-14 2008-11-20 Shanghai Hengrui Pharmaceutical Co.Ltd. Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases

Also Published As

Publication number Publication date
JP5342547B2 (ja) 2013-11-13
CA2685757A1 (fr) 2008-11-20
KR20100022003A (ko) 2010-02-26
CN101675061A (zh) 2010-03-17
CN101307052B (zh) 2011-08-17
EP2157093A4 (fr) 2012-03-07
MX2009011964A (es) 2009-12-01
AU2008250895A1 (en) 2008-11-20
JP2010526838A (ja) 2010-08-05
EP2157093A1 (fr) 2010-02-24
UA99617C2 (ru) 2012-09-10
BRPI0811865A2 (pt) 2014-11-18
US8329682B2 (en) 2012-12-11
TWI409263B (zh) 2013-09-21
CN101307052A (zh) 2008-11-19
US20100075952A1 (en) 2010-03-25
CN101675061B (zh) 2012-07-04
AU2008250895B2 (en) 2012-08-02
RU2009141799A (ru) 2011-06-20
HK1137027A1 (en) 2010-07-16
WO2008138184A1 (fr) 2008-11-20
TW200946530A (en) 2009-11-16
US20130303518A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
HK1121757A1 (en) Pyrroloazacyclic derivatives, preparing method and use thereof
IL238438A0 (en) 2,2,2-trifluoroacetophenones and a method for their preparation
EP2151500A4 (fr) -glucan ramifié, -glucosyltransférase produisant celui-ci, son procédé de fabrication et son utilisation
EP2124550A4 (fr) Oxabicycloheptanes et oxabicycloheptènes, leur préparation et leur utilisation
HK1117164A1 (en) Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof
GB0709910D0 (en) Stents, devices for use with stents and method relating thereto
ZA201005202B (en) Azabicyclic carboxamide derivatives,preparation thereof and theapeutic use thereof
EP1990337A4 (fr) Dérivés de quinazoline, leurs procédés de fabrication et utilisations
PL1997500T3 (pl) Herbata lecznicza i sposób jej przygotowania
EP2235854A4 (fr) Adaptateur, dispositif et procédé
HK1151791A1 (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
EP1988090A4 (fr) Dérivés d'acide imidazol-5-carboxylique, leurs procédés de préparation et leur utilisation
HK1159108A1 (en) Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
PL2155824T3 (pl) Preparat pigmentowy, sposób jego wytwarzania i jego zastosowanie
EP2233443A4 (fr) Appareil de façonnage-chauffage de panneau de verre et procédé de ceintrage-façonnage de panneau de verre
EP2283005A4 (fr) Dérivés de cisatracurium, préparation et utilisations de ceux-ci
EP2211851A4 (fr) Laminines, dérivés, compositions les contenant, et procédé pour leur utilisation thérapeutique
EP2470499A4 (fr) Nouveaux dérivés de colchicine, leurs procédés et utilisations
IL240648A (en) METHOD FOR PREPARING ISOPGOMIN AND ITS DERIVATIVES
GB0719592D0 (en) Compound, use and method
HK1120837A1 (en) Elastic interlining, method for its manufacture and use
HK1140772A1 (en) Ginsenoside, preparation method thereof and use thereof
EP2344479A4 (fr) Dérivés de 1,2-benzisothiazolinone et d'isoindolinone
EP2368705A4 (fr) Procédé de fabrication de pochette ainsi que pochette
HRP20160578T1 (hr) Supstituirani furankarboksamidi i njihova upotreba

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160411